News | Women's Health | July 24, 2020

Ikonopedia Selected for an Enterprise-wide Breast Reporting and Risk Assessment Implementation at Intermountain Healthcare

July 24, 2020 — Ikonopedia announced that Intermountain Healthcare, based in Salt Lake City, Utah, has selected the company's structured breast reporting and risk assessment tools to help improve reporting quality, efficiency, and maintain patient safety. 

The system-wide implementation will be initiated at six Intermountain Healthcare's hospitals, including the Janice Beesley Hartvigsen Breast Care Center at Intermountain Medical Center, and features integration with the Cerner EHR and other imaging systems.

Intermountain Healthcare employees nearly 40,000 caregivers who serve the healthcare needs of people across the Intermountain West. Intermountain Healthcare performs more than 160,000 mammography exams a year, as well as provides comprehensive treatment for breast cancer and other breast-related conditions, at more than 25 locations in Utah, southern Idaho, and southern Nevada.

Intermountain Healthcare was named as one of "Health Care's Most Wired" for 2016 by Hospitals & Health Networks magazine. The list is based on a collaborative study conducted by H&HN and  the American Health AssociationIntermountain has been named among the nation's most technologically savvy hospital systems in 17 of the 18 years the survey has been conducted.

"While we expect Ikonopedia's innovative Cloud-based structured breast reporting system to bring significant efficiency gains to our technologists and radiologists, the focus is on providing high-quality and safe care to every one of our patients," said Brett Parkinson, M.D., imaging director and medical director for breast care services at Intermountain. "This starts with utilizing intuitive, easy to use reporting and risk assessment tools and closed-loop follow-up system to make sure that every patient and every clinical finding is monitored and fully resolved."  

Ikonopedia is an innovative structured breast reporting and MQSA management system designed to dramatically improve reporting efficiency and optimize facility operations. All findings are saved as discrete data, which allows Ikonopedia to prevent errors, maintain BI-RADS-compliant language and automate many time-consuming processes. Ikonopedia makes it possible to eliminate laterality errors, automatically choose exam-appropriate patient letters, and pull forward findings from past exams along with many other time-saving features. 

Ikonopedia's integrated risk assessment tool is now available in dozens of languages and risk data is used to create alerts for the radiologist, populate the clinical section of the report, and automatically update the patient letter. A high-risk patient alert identifies patients with a 20% or greater lifetime risk and information about the score is instantly viewable.

"Intermountain Healthcare is well known for using technology to improve patient care, efficiency, and safety. We are proud to work with Intermountain to deliver robust breast reporting and risk-assessment tools that help ensure that women get accurate and timely information about their breast care, which can lead to better outcomes for their patients and caregivers," said Emily Crane, CEO of Ikonopedia.

For more information: www.ikonopedia.com

Related Content

The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the

A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant therapy shows new mass (arrow) in upper outer left breast that was assessed as BI-RADS 4. Pathologic examination from MRI-guided core biopsy of new suspicious mass revealed benign usual ductal hyperplasia. No atypia or malignancy was identified. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | MRI Breast | January 15, 2021
January 15, 2021 — According to ARRS' ...
A targeted intervention providing mammograms to hospitalized Medicaid patients can help patients complete overdue breast cancer screening

Getty Images

News | Mammography | January 14, 2021
January 14, 2021 — Completing cancer screening tests, such as...
DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content
News | Breast Density | January 13, 2021
January 13, 2021 — DenseBreast-info.org (DB-I) invites he
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately
News | Mammography | January 12, 2021
January 12, 2021 — Therapixel announced that...
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.